Synairgen plc (LON:SNG – Get Rating) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 22.91 ($0.28) and traded as low as GBX 16.10 ($0.20). Synairgen shares last traded at GBX 16.80 ($0.21), with a volume of 218,665 shares changing hands.
Synairgen Stock Up 5.0 %
The company has a quick ratio of 6.35, a current ratio of 6.35 and a debt-to-equity ratio of 0.09. The company has a market capitalization of £33.83 million and a price-to-earnings ratio of -0.69. The stock's fifty day moving average price is GBX 18.65 and its 200-day moving average price is GBX 22.91.
About Synairgen
(Get Rating)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Recommended Stories
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
- Inflation and the Energy Crisis are Two Freight Trains on a Collision Course – Here's How to Prepare
- Is Enterprise Products Partners Fairly Valued?
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.